| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2020 | A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients | Wang Y.-H.; CHIEN-CHIN LIN ; Yao C.-Y.; Hsu C.-L.; Hou H.-A.; Tsai C.-H.; Chou W.-C.; Tien H.-F. | Blood Advances | 7 | 7 | |
| 2017 | A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes | Yao C.-Y.; Chen C.-H.; Huang H.-H.; Hou H.-A.; CHIEN-CHIN LIN ; Tseng M.-H.; Kao C.-J.; Lu T.-P.; Chou W.-C.; Tien H.-F. | Blood Advances | 12 | 11 | |
| 2020 | ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden | Wang Y.-H.; CHIEN-CHIN LIN ; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; Chou W.-C.; Tang J.-L.; Tien H.-F. | Blood Cancer Journal | 2 | 2 | |
| 2021 | A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes | Wang, Yu-Hung; Hou, Hsin-An; CHIEN-CHIN LIN ; Kuo, Yuan-Yeh; Yao, Chi-Yuan; Hsu, Chia-Lang; Tseng, Mei-Hsuan; Tsai, Cheng-Hong; Peng, Yen-Ling; Kao, Chein-Jun; Chou, Wen-Chien; Tien, Hwei-Fang | Blood advances | | 0 | |
| 2021 | Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML | Tsai, Cheng-Hong; Tang, Jih-Luh; TIEN FENG-MING; Kuo, Yuan-Yeh; Wu, Dung-Chi; CHIEN-CHIN LIN ; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hou, Mei-Fang; Chuang, Yi-Kuang; Liu, Ming-Chih; Liu, Chia-Wen; MING YAO; Lin, Liang-In; Chou, Wen-Chien; Chen, Chien-Yu; Hou, Hsin-An; Tien, Hwei-Fang | Blood advances | 7 | 7 | |
| 2014 | Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression | Hou H.-A.; Kuo Y.-Y.; Tang J.-L.; Chou W.-C.; Yao M.; Lai Y.-J.; CHIEN-CHIN LIN ; Chen C.-Y.; Liu C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Huang S.-Y.; Ko B.-S.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. | American Journal of Hematology | 52 | 48 | |
| 2017 | Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia | Hou H.-A.; Lu J.-W.; Lin T.-Y.; Tsai C.-H.; Chou W.-C.; CHIEN-CHIN LIN ; Kuo Y.-Y.; Liu C.-Y.; Tseng M.-H.; Chiang Y.-C.; Peng Y.-L.; Tang J.-L.; Gong Z.; Lin L.-I.; Tien H.-F. | Blood cancer journal | 8 | 6 | |
| 2022 | Cutaneous presentation of disseminated cytomegalovirus infection in a non-transplant patient with hematological malignancy: A case report | Yu, Hung-Chuan; Liu, Wang-Da; Kuo, Po-Hsien; CHIEN-CHIN LIN ; Wu, Un-In | Medicine | 0 | 0 | |
| 2020 | Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax | Wang Y.-W.; Tsai C.-H.; CHIEN-CHIN LIN ; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F. | Annals of Hematology | 31 | 29 | |
| 2019 | Determinants of satisfactory patient communication and shared decision making in patients with multiple myeloma | Nejati B.; CHIEN-CHIN LIN ; Aaronson N.K.; Cheng A.S.K.; Browall M.; Lin C.-Y.; Brostr?m A.; Pakpour A.H. | Psycho-Oncology | 10 | 7 | |
| 2017 | The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse model | Hsu Y.-C.; Chiu Y.-C.; CHIEN-CHIN LIN ; Kuo Y.-Y.; Hou H.-A.; Tzeng Y.-S.; Kao C.-J.; Chuang P.-H.; Tseng M.-H.; Hsiao T.-H.; Chou W.-C.; Tien H.-F. | Journal of Hematology and Oncology | 24 | 23 | |
| 2021 | Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125 | Wang Y.-H.; CHIEN-CHIN LIN ; Hsu C.-L.; Hung S.-Y.; Yao C.-Y.; Lee S.-H.; Tsai C.-H.; Hou H.-A.; Chou W.-C.; Tien H.-F. | Annals of Hematology | 5 | 5 | |
| 2016 | Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS) | Yao C.-Y.; Hou H.-A.; Lin T.-Y.; CHIEN-CHIN LIN ; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Kuo Y.-Y.; Wu S.-J.; Liao X.-W.; Lin C.-T.; Ko B.-S.; Chen C.-Y.; Hsu S.-C.; Li C.-C.; Huang S.-Y.; Yao M.; Tang J.-L.; Tsay W.; Liu C.-Y.; Tien H.-F. | Oncotarget | 13 | 14 | |
| 2020 | The expression levels of long non-coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes | Hung S.-Y.; CHIEN-CHIN LIN ; Hsu C.-L.; Yao C.-Y.; Wang Y.-H.; Tsai C.-H.; Hou H.-A.; Chou W.-C.; Tien H.-F. | British Journal of Haematology | 3 | 2 | |
| 2015 | GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution | Hou H.-A.; Lin Y.-C.; Kuo Y.-Y.; Chou W.-C.; CHIEN-CHIN LIN ; Liu C.-Y.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. | Annals of Hematology | 18 | 17 | |
| 2016 | Genetic alterations and their clinical implications in older patients with acute myeloid leukemia | Tsai C.-H.; Hou H.-A.; Tang J.-L.; Liu C.-Y.; CHIEN-CHIN LIN ; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Kuo Y.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Tsay W.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tien H.-F. | Leukemia | 83 | 77 | |
| 2017 | Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia | CHIEN-CHIN LIN ; Hsu Y.-C.; Li Y.-H.; Kuo Y.-Y.; Hou H.-A.; Lan K.-H.; Chen T.-C.; Tzeng Y.-S.; Kuo Y.-Y.; Kao C.-J.; Chuang P.-H.; Tseng M.-H.; Chiu Y.-C.; Chou W.-C.; Tien H.-F. | Haematologica | 23 | 23 | |
| 2014 | IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution | CHIEN-CHIN LIN ; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Chen C.-Y.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. | American Journal of Hematology | 69 | 66 | |
| 2021 | Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome | Wang, Yu-Hung; CHIEN-CHIN LIN ; Yao, Chi-Yuan; Hsu, Chia-Lang; Tsai, Cheng-Hong; Hou, Hsin-An; Chou, Wen-Chien; Tien, Hwei-Fang | British journal of haematology | 1 | 1 | |
| 2019 | Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients | Tsai C.-H.; Yao C.-Y.; Tien F.-M.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; CHIEN-CHIN LIN ; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Tien H.-F. | EBioMedicine | 12 | 13 | |
